Multiple Myeloma: Sequencing Novel Therapies in Later Lines of Treatment
Focused discussion on the sequencing of bispecifics or CAR T-cell therapies in patients with multiply relapsed multiple myeloma.
Source: onclive.com
Page 14 - Recent Updates News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Recent Updates. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Recent Updates Today - Breaking & Trending Today
Treatment Strategy in Patients with Unresectable Stage I-III NSCLC
Expert panelists discuss the characterization of patients with unresectable, early-stage NSCLC and what their standard treatment approach is for this patient population.
Source: onclive.com
Patient Profile: A 79-Year-Old Man With Lower-Risk MDS and a KRAS Mutation
Yazan Madanat, MD, presents the patient profile of a transfusion-dependent 79-year-old man with lower-risk MDS and a KRAS mutation.
Source: onclive.com
Consolidation Immunotherapy in Unresectable Early NSCLC: PACIFIC Study
Ben Levy, MD, reviews the 5-year update and clinical implications of the PACIFIC study which evaluated consolidation immunotherapy in unresectable early-stage NSCLC.
Source: onclive.com
Treatment Approaches for Lower-Risk MDS With RAS Mutations
The panel discusses the patient profile of a man with lower-risk MDS and how they would have approached treatment in their practice.
Source: onclive.com